Medline (MDLN) Depreciation & Amortization (CF) (2025 - 2026)

Medline (MDLN) has reported Depreciation & Amortization (CF) for 2 consecutive years, with $254.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 2.83% year-over-year to $254.0 million; the TTM figure through Mar 2026 stood at $501.0 million (changed N/A YoY), while the FY2025 annual figure was $1.0 billion, up 3.48% from the prior year.
• Depreciation & Amortization (CF) advanced to $254.0 million in Q1 2026 per MDLN's latest filing, from $247.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $254.0 million in Q1 2026 and bottomed at $247.0 million in Q1 2025.